Utility of dynamic susceptibility contrast MRI for differentiation between paragangliomas and meningiomas in the cerebellopontine angle and jugular foramen region
Clinical Imaging · 2023
DOI: 10.1016/j.clinimag.2022.12.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Imaging, 2023. Verfasst von Yoshiaki Ota und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI 48109, USA. Electronic ad…. Hauptthemen laut MEDLINE: Meningioma, Jugular Foramina, Meningeal Neoplasms. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Differentiation of paragangliomas and meningiomas can be a challenge. This study aimed to assess the utility of dynamic susceptibility contrast perfusion MRI (DSC-MRI) to distinguish paragangliomas from meningiomas. METHODS: This retrospective study included 40 patients with paragangliomas and meningiomas in the cerebellopontine angle and jugular foramen region between March 2015 and February 2022 in a single institution. Pretreatment DSC-MRI and conventional MRI were performed in all cases. Normalized relative cerebral blood volume (nrCBV), relative cerebral blood flow (nrCBF), relative mean transit time (nrMTT), and time to peak (nTTP) as well as conventional MRI features were compared between the 2 tumor types and between meningioma subtypes as appropriate. Receiver operating characteristic curve and multivariate logistic regression analysis were performed. RESULTS: Twenty-eight meningiomas including 8 WHO grade II meningiomas (12 males, 16 females; median age 55 years) and 12 paragangliomas (5 males, 7 females; median age 35 years) were included in this study. Paragangliomas had a higher rate of cystic/necrotic changes (10/12 vs 10/28; P = 0.014), a higher rate of internal flow voids (9/12 vs 8/28; P = 0.013), higher nrCBV (median 9.78 vs 6.64; P = 0.04), and shorter nTTP (median 0.78 vs 1.06; P < 0.001) than meningiomas. There was no difference in conventional imaging features and DSC-MRI parameters between meningioma subtypes. nTTP was identified as the most significant parameter for the 2 tumor types in the multivariate logistic regression analysis (P = 0.009). CONCLUSIONS: In this small retrospective study, DSC-MRI perfusion differences were observed between paragangliomas and meningiomas, but not between grade I and II meningiomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI 48109, USA. Electronic address: yoshiako@med.umich.edu.
- Division of Neuroradiology, Department of Radiology, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI 48109, USA.
Zitieren
APA
Ota, Y., Liao, E., Zhao, R., Capizzano, A. A., Baba, A., Lobo, R., Shah, G., & Srinivasan, A. (2023). Utility of dynamic susceptibility contrast MRI for differentiation between paragangliomas and meningiomas in the cerebellopontine angle and jugular foramen region. Clinical Imaging. https://doi.org/10.1016/j.clinimag.2022.12.014
Vancouver
Ota Y, Liao E, Zhao R, Capizzano AA, Baba A, Lobo R, et al. Utility of dynamic susceptibility contrast MRI for differentiation between paragangliomas and meningiomas in the cerebellopontine angle and jugular foramen region. Clinical Imaging. 2023. doi:10.1016/j.clinimag.2022.12.014
BibTeX
@article{Ota2023,
author = {Ota, Yoshiaki and Liao, Eric and Zhao, Raymond and Capizzano, Aristides A and Baba, Akira and Lobo, Remy and Shah, Gaurang and Srinivasan, Ashok},
title = {Utility of dynamic susceptibility contrast MRI for differentiation between paragangliomas and meningiomas in the cerebellopontine angle and jugular foramen region},
journal = {Clinical Imaging},
year = {2023},
doi = {10.1016/j.clinimag.2022.12.014}
}
EUVIMED